Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
alzheimer's disease
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
3
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
3
×
texas blog main
texas top stories
wisconsin blog main
3
×
wisconsin top stories
bristol-myers squibb
cancer
clinical trials
crispr therapeutics
cystic fibrosis
deals
diagnostics
What
bio
drug
roundup
acquisitions
albert
alzheimer’s
annual
approval
assessed
attention
biggest
biogen’s
biopharmaceutical
biotech
bourla
ceo
communities
companies
company
conference
convo
crispr
earlier
esmo
europe
failures
future
germany
hosted
imports
investment
littered
maker
maps
measured
munich
nash
new
news
patients
Language
unknown
Current search:
medicare
×
startups
×
" wisconsin blog main "
×
abbvie
×
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More